Reader Login
| Users Online: 76
Search Article
Advanced search
Home
|
About us
|
Editorial board
|
Search
|
Ahead of print
|
Current issue
|
Archives
|
Submit article
|
Instructions
|
Subscribe
|
Contacts
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Citation statistics : Table of Contents
2015| January-March | Volume 36 | Issue 1
Online since
November 4, 2015
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Cited
Viewed
PDF
CLINICAL RESEARCH
A pilot study on Ayurvedic management of oral submucous fibrosis
Kundan R Patel, Manjusha Rajagopala, Dharmendrasinh B Vaghela, Ashok Shah
January-March 2015, 36(1):34-40
DOI
:10.4103/0974-8520.169018
PMID
:26730136
Introduction:
Oral submucous fibrosis (OSMF) is a chronic debilitating disease and a well-recognized potentially premalignant condition of the oral cavity. Various medical and surgical treatment modalities have been used in modern science, but results are not satisfactory owing to recurrence, adverse effects, and sometimes worsening the condition. On analyzing the disease condition with Ayurvedic approach, it seems to be nearer to
Vata-Pitta
dominant chronic
Sarvasara Mukharoga
and needs to be treated at local as well as systemic level.
Aim:
To evaluate the effect of proposed Ayurvedic treatment protocol in the patients of OSMF.
Materials and Methods:
It was an open-label nonrandomized clinical trial with black box design comprising of holistic Ayurvedic approach in which 22 patients of OSMF completed the treatment. In all of them after
Koshthashuddhi
(mild purgation) and
Shodhana Nasya
(errhine therapy);
Pratisarana
(external application) with
Madhupippalyadi Yoga
,
Kavala
(gargling) with
Ksheerabala Taila
and internally
Rasayana Yoga
were given for 2 months and followed for 1 month.
Results:
It revealed statistically highly significant relief in almost all signs and symptoms as well in inter incisal distance improvement. Furthermore, sustained relief was found in follow-up.
Conclusion:
Ayurvedic treatment protocol is effective in the management of OSMF.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
37
15,915
1,008
Efficacy of
Ashwagandha
(
Withania somnifera
[L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults
Bakhtiar Choudhary, A Shetty, Deepak G Langade
January-March 2015, 36(1):63-68
DOI
:10.4103/0974-8520.169002
PMID
:26730141
Introduction:
Ashwagandha
(
Withania somnifera
[L.] Dunal) has been traditionally used for various actions ranging from vitalizer, improve endurance and stamina, promote longevity, improve immunity, and male and female fertility. However, clinical studies are needed to prove the clinical efficacy of this herb, especially in cardiovascular endurance and physical performance.
Aims:
This prospective, double-blind, randomized, and placebo-controlled study evaluated the efficacy of
Ashwagandha
roots extract in enhancing cardiorespiratory endurance and improving the quality of life (QOL) in 50 healthy male/female athletic adults.
Materials and Methods:
Cardiorespiratory endurance was assessed by measuring the oxygen consumption at peak physical exertion (VO
2
max) levels during a 20 m shuttle run test. The World Health Organization self-reported QOL questionnaire (physical health, psychological health, social relationships, and environmental factors) was used to assess the QOL. Student's
t
-test was used to compare the differences in a mean and change from baseline VO
2
max levels, whereas Wilcoxon signed-rank test was used to assess changes in QOL scores from baseline in the two groups.
Results:
There was a greater increase from baseline (
P
< 0.0001) in the mean VO
2
max with KSM-66
Ashwagandha
(
n
= 24) compared to placebo (
n
= 25) at 8 weeks (4.91 and 1.42, respectively) and at 12 weeks (5.67 and 1.86 respectively). The QOL scores for all subdomains significantly improved to a greater extent in the
Ashwagandha
group at 12 weeks compared to placebo (
P
< 0.05).
Conclusion:
The findings suggest that
Ashwagandha
root extract enhances the cardiorespiratory endurance and improves QOL in healthy athletic adults.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
22
14,833
1,956
A comparative clinical study on the effect of
Tagara (Valeriana wallichii
DC.) and
Jatamansi (Nardostachys jatamansi
DC.) in the management of
Anidra
(primary insomnia)
E Toolika, Narayana Prakash Bhat, Suhas Kumar Shetty
January-March 2015, 36(1):46-49
DOI
:10.4103/0974-8520.169008
PMID
:26730138
Introduction:
The World Health Organization's 2004 Global Burden of Disease report indicated 3.6 million years of productive, healthy life is lost worldwide as a result of primary insomnia. Approximately 30–35% of people meet diagnostic criteria for primary insomnia characterized by impairment resulting from problems of falling and staying asleep.
Aims:
To evaluate the effect of
Tagara
(
Valeriana wallichii
DC.) and
Jatamansi
(
Nardostachys jatamansi
DC.) in the management of
Anidra.
Materials and Methods: A
total of 34 patients were selected fulfilling the criteria for inclusion for primary insomnia were randomly selected from Out Patient Department and In Patient Department of
Manasa Roga
and assigned into two groups, wherein 30 patients completed the study (15 in each).
Tagara Churna
(powder of
V. wallichii
) and
Jatamansi Churna
(powder of
N. jatamansi
) in the dose of 4 gm with milk was administered three times a day for a period of 1 month.
Results:
Tagara
provided significant improvement in initiation of sleep (76.00%;
P
< 0.001), duration of sleep (55.17%;
P
< 0.001), disturbed sleep (69.58%;
P
< 0.001), and disturbances in routine work (73.95%;
P
< 0.001).
Jatamansi
provided improvement in initiation of sleep (61.34%;
P
< 0.001), duration of sleep (48.25%;
P
< 0.001), disturbed sleep (53.08%;
P
< 0.001), and disturbance in routine works (43.85%;
P
< 0.001).
Conclusion:
Both the groups showed good results, but
Tagara
group showed better results in comparison to
Jatamansi
group.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
18
5,353
729
PHARMACOLOGICAL STUDY
Experimental studies on glycolytic enzyme inhibitory and antiglycation potential of
Triphala
Aditya Ganeshpurkar, Shubhangi Jain, Sonam Agarwal
January-March 2015, 36(1):96-100
DOI
:10.4103/0974-8520.169000
PMID
:26730147
Introduction:
Imbalance in cellular metabolism of carbohydrates and lipids is observed in diabetes mellitus. Pancreatic α-amylase and α-glucosidases are responsible for the conversion of polysaccharides into glucose that enters in the blood stream.
Triphala
has shown antidiabetic effects (type 2) in human subjects. However, its effects on glycolytic enzymes and protein glycation have not been studied.
Aim:
To evaluate glycolytic enzyme inhibitory and antiglycation potential of
Triphala
.
Materials and Methods:
Triphala Churna
was extracted with cold water and subjected to phytochemical analysis. Studies on α amylase and α glucosidase inhibition were performed, and its antiglycation potential was determined.
Results:
Triphala
extract showed prominent α-amylase inhibitory potential (48.66% at concentration 250 μg/ml). Percent α-glucosidase inhibition increased with increasing concentration of the extract (6.32–40.64%). Extract showed remarkable results for antiglycation potential.
Triphala
extract showed glycation inhibition by inhibiting fructosamine; fructosamine inhibition was found to be 37.74%, protein carbonyls were inhibited up to 15.23% whereas protein thiols were inhibited up to 84.81%.
Conclusion:
Triphala
showed glycolytic enzyme inhibitory and antiglycation potential. Hence, it can be effectively used in the diabetes management.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
12
4,715
426
REVIEW ARTICLE
Role of AYUSH workforce, therapeutics, and principles in health care delivery with special reference to National Rural Health Mission
Janmejaya Samal
January-March 2015, 36(1):5-8
DOI
:10.4103/0974-8520.169010
PMID
:26730131
Decades back AYUSH systems of medicine were limited to their own field with few exceptions in some states as health in India is a state issue. This took a reverse turn after the initiation of National Rural Health Mission (NRHM) in 2005 which brought the concept of "Mainstreaming of AYUSH and Revitalization of Local Health Traditions" utilizing the untapped AYUSH workforces, therapeutics and principles for the management of community health problems. As on 31/03/2012 AYUSH facilities were co-located in 468 District Hospitals, 2483 Community Health Centers and 8520 Primary Health Centers in the country. Several therapeutics are currently in use and few drugs have been included in the ASHA drug kit to treat common ailments in the community. At the same time Government of India has recognized few principles and therapeutics of Ayurveda as modalities of intervention to some of the community health problems. These include
Ksharasutra
(medicine coated thread) therapy for ano-rectal surgeries and
Rasayana Chikitsa
(rejuvenative therapy) for senile degenerative disorders etc. Similarly respective principles and therapeutics can also be utilized from other systems of AYUSH such as Yoga and Naturopathy, Unani, Siddha and Homoeopathy. Akin to Ayurveda these principles and therapeutics can also help in managing community health problems if appropriately implemented. This paper is a review on the role of AYUSH, as a system, in the delivery of health care in India with special reference to National Rural Health Mission.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
11
8,017
1,145
PHARMACOLOGICAL STUDY
Protective effect of
Agave americana
Linn. leaf extract in acetic acid-induced ulcerative colitis in rats
Basheerahmed A.A Mannasaheb, Preeti V Kulkarni, Mashood Ahmed Sangreskopp, Chetan Savant, Anjana Mohan
January-March 2015, 36(1):101-106
DOI
:10.4103/0974-8520.168998
PMID
:26730148
Introduction:
Natural plants always provide core compounds for new drug development. In the present life and food style, inflammatory bowel disease has become common and needs a lead compound for its drug development.
Aim:
To evaluate the effect of
Agave americana
Linn. leaf extract in acetic acid-induced ulcerative colitis in rats based on its traditional anti-inflammatory use.
Materials and Methods:
Male Wistar rats were pretreated with
A. americana
leaf extract in the dose of 200 and 400 mg/kg p.o. daily for 7 days. On 8
th
day, 2 ml of 4% v/v acetic acid in saline was instilled into rats' rectum. Prednisolone was used as standard drug and it was administered on the day of acetic acid instillation and continued for 3 days. Extract treatment was continued till 11
th
day. Body weight, ulcer score, colonic muscle contraction, antioxidant activity and histopathology were studied. Statistical analysis was performed using Parametric one-way analysis of variance followed by Tukey's posttest.
Results:
A. americana
have retained total body weight significantly (
P
< 0.01) and decreased colon weight/length ratio. Extract have shown a significant decrease (
P
< 0.001) in ulcer scores, myeloperoxidase, lipid peroxidase activity. Further, extract have shown significant improvement in colonic muscle contraction, histopathology of colon etc., which is comparable with standard drug.
Conclusion:
A. americana
possess protective effect against acetic acid-induced colitis in rats.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
7
4,364
447
Anti-diabetic activity of methanolic extract of
Alpinia galanga
Linn. aerial parts in streptozotocin induced diabetic rats
Ramesh Kumar Verma, Garima Mishra, Pradeep Singh, Keshri K Jha, Ratan L Khosa
January-March 2015, 36(1):91-95
DOI
:10.4103/0974-8520.169006
PMID
:26730146
Introduction:
Alpinia galanga
Linn. belongs to the family Zingiberaceae has been used as a traditional medicine in China for relieving stomach ache, treating cold, invigorating the circulatory systems, diabetes, and reducing swelling.
Aim:
To evaluate the antidiabetic activity of methanolic extract of
A. galanga
aerial parts on streptozotocin (STZ) induced diabetic rats.
Materials and Methods:
Diabetes was induced by single intraperitoneal injection of STZ at a dose of 60 mg/kg bodyweight. Test drug methanolic extract of
A. galanga
(200 and 400 mg/kg b.w.) and glibenclamide (10 mg/kg b.w.) as standard drug was administered orally for 21 consecutive days in STZ-induced diabetic rats. Fasting blood glucose level, serum lipid profiles, as well as initial and final changes in body weight were assessed along with histopathology. All the parameters were statistically analyzed by using one-way ANOVA followed by Bonferroni
t
-test.
Results:
Experimental findings showed significant dose dependent antidiabetic potential of methanolic extract in terms of reduction of fasting blood glucose level and various biochemical parameters in diabetic rats when compared with that of the diabetic control group, which might be due to the stimulatory effect of methanolic extracts on the regenerating β-cells and also on the surviving β-cells.
Conclusion:
Methanolic extract of aerial parts of
A. galanga
was effective in controlling blood glucose level and improve lipid profile in euglycemic as well as diabetic rats.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
7
4,199
489
ORIGINAL ARTICLE - SURVEY STUDY
Rising risk of type 2 diabetes among inhabitants of Jamnagar, Gujarat: A cross-sectional survey
Rohit Sharma, Pradeep Kumar Prajapati
January-March 2015, 36(1):10-17
DOI
:10.4103/0974-8520.169014
PMID
:26730132
Introduction:
Undoubtedly, diabetes is an incremental threat for the world health and substantial evidence now suggest that diabetes is strongly associated with patients' unhealthy lifestyle, behavioral patterns, and socioeconomic changes. Treatment modalities, in particular to this disease differs from patient to patient. In Ayurveda, this individuality is decided on the basis of
Prakriti, Vaya, Bala, Desha
etc., and hence it is essential to know these factors for successful management of diseases.
Aim:
To assess the role of demographic profile, changes in life style habits, dietary patterns, occupational and social background in increasing prevalence of type 2 diabete mellitus (DM) at Jamnagar region.
Materials and Methods:
A cross-sectional survey study was conducted on randomly selected 350 diabetic patients of Jamnagar region. A survey proforma was prepared and detailed history of each patient fulfilling the diagnostic criteria was taken along with demographic profile.
Observations and Conclusion:
The obtained data reveals that, certain faulty dietary and life style regimes of this region are responsible in manifestation of DM. Its magnitude and low awareness warrants appropriate public health interventions for its effective control.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
6
5,082
977
PHARMACOLOGICAL STUDY
Safety and efficacy of hydroalcoholic extract from
Lawsonia inermis
leaves on lipid profile in alloxan-induced diabetic rats
Surender Singh, Nishikant Verma, Ritu Karwasra, Prerna Kalra, Rohit Kumar, Yogendra Kumar Gupta
January-March 2015, 36(1):107-112
DOI
:10.4103/0974-8520.168999
PMID
:26730149
Introduction:
Dyslipidemia is one of the most common risk factor for cardiac-related disorders in diabetes mellitus. Diabetic dyslipidemia is characterized by hypertriglyceridemia, low high density lipoprotein and elevated low density lipoprotein concentration.
Aim:
To explore the effect of
Lawsonia inermis
hydroalcoholic extract (LIHE) for diabetic dyslipidemic activity along with its safety profile.
Materials and Methods:
LIHE administered at doses of 100, 200 and 400 mg/kg in rats after induction of hyperglycemia by alloxan. Insulin (1 IU/kg), glibenclamide (2.5 mg/kg), and metformin (100 mg/kg) were used as positive control and 1% gum acacia as normal control. Statistical analysis was performed using one-way analysis of variance, followed by Dunnett's
t
-test.
Results:
The percentage reduction in blood glucose level of LIHE at dose of 400 mg/kg was 39.08% on day 21 when compared to baseline (day 0), which is comparable to glibenclamide (44.77%) and metformin (46.30%). Decrease in blood glucose level exhibited significant improvement in lipid profile, plasma albumin, total plasma protein and serum creatinine.
Conclusion:
Results of this study demonstrated that LIHE significantly improved lipid and lipoprotein pattern observed in diabetic rats and this could be due to improvement in insulin secretion or action, thus has potential to be used in treatment of diabetes mellitus associated dyslipidemia.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5
3,061
316
CASE STUDY
Ayurvedic management of life-threatening skin emergency erythroderma: A case study
Sarvesh Kumar Singh, Kshipra Rajoria
January-March 2015, 36(1):69-72
DOI
:10.4103/0974-8520.169015
PMID
:26730142
Erythroderma or generalized exfoliative dermatitis is a skin disorder that requires attention equivalent to medical emergencies. It is more prevalent in male population. It accounts for 35 cases/100,000 cases in dermatologic outpatient departments. In erythroderma even with proper management there are certain metabolic burdens and complications which make it more critical. The primary aim, in this case, was to treat the patient with Ayurvedic management. A 18-year-old patient, suffering from erythroderma, was treated on the line of
Kapala Kushtha
and
Audumbera Kushtha
. The patient had primarily suffered from psoriasis for 8 years. Erythroderma was developed due to abrupt self-medication with an unknown amount of intramuscular methylprednisolone several times in last month.
Rasamanikya
-125 mg,
Arogyavardhini Vati-
1 g,
Kaishora Guggulu-
1 g,
Khadirarista-
20 ml, and
Panchatikta Ghrita-
20 ml, all drugs twice a day with 3-4 times local application of
Jatyadi Taila
were administered. A decoction of
Jwarhara Kashaya
was also administered in the dose of 40 ml twice a day. The patient had relief from the acute phase after 20 days of treatment and complete remission after 3 months of treatment. This case study demonstrates that Ayurvedic management may be useful in erythroderma like acute and life-threatening condition.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4
4,575
589
CLINICAL RESEARCH
Randomized placebo-controlled clinical study on enhancement of
Medha
(intelligence quotient) in school going children with
Yahstimadhu
granules
Srihari Sheshagiri, Kalpana S Patel, S Rajagopala
January-March 2015, 36(1):56-62
DOI
:10.4103/0974-8520.169011
PMID
:26730140
Introduction:
Optimal intelligence is a vital essentiality in day-to-day life, especially in children who have to build up their life in an apt manner.
Yashtimadhu
(
Glycyrrhiza glabra
Linn) is a time tested classical drug indicated for promotion of mental health mentioned in Ayurveda which may also help children to attain optimal intelligence.
Aim:
To evaluate the role of
Yashtimadhu
(
Glycyrrhiza glabra
Linn.) granules in enhancement of
Medha
(intelligence quotient [IQ]).
Materials and Methods:
The study was conducted on healthy school going children aged 14–16 years. Total 94 children were registered and divided into two groups.
Yashtimadhu
granules was administered in Group A and Wheat flour in the form of granules in Group B, the duration of treatment was 12 weeks with follow up of additional 12 weeks. Objective parameters included assessment of functional aspects of
Buddhi
(psychological faculty for reasoning and logic) along with the assessment of IQ, Quality of life parameters and general health condition.
Results:
Yashtimadhu
granules showed statistically highly significant results in improving functional aspects of
Buddhi,
IQ, several aspects of quality of life parameters and health
.
The number needed to treat (NNT) with
Yashtimadhu
granules for children achieving an IQ score of 90 and above was 3.38, suggesting one in every 3.38 patients had achieved this target and for children achieving an IQ score of 110 and above the NNT was 6.66.
Conclusion:
Yashtimadhu
granules was safe throughout the course of study and indeed possessed a significant efficacy in improving
Medha
(IQ).
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4
4,183
648
MESSAGE FROM THE VICE CHANCELLOR
Ayurveda research publications: A serious concern
Vaidya Rajesh Kotecha
January-March 2015, 36(1):1-2
DOI
:10.4103/0974-8520.169004
PMID
:26730129
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4
3,468
544
PHARMACEUTICAL STANDARDIZATION
Fourier transform infrared analysis of
Tamra Bhasma
at different levels: A preliminary study
Swapnil Y Chaudhari, Dhirajsingh S Rajput, R Galib, Pradeep Kumar Prajapati
January-March 2015, 36(1):77-82
DOI
:10.4103/0974-8520.169013
PMID
:26730144
Introduction:
Tamra Bhasma
, one among the herbo-metallic preparations is extensively used in Ayurveda for different conditions. To make it safe to use,
Tamra
has to pass through a set of classical pharmaceutical procedures including a series of quenching in prescribed liquids, followed by incineration with black sulfide of mercury and herbal juice of
Citrus jambhiri
Lush. and corm of
Amorphophallus campanulatus
Linn. FTIR profiles of
Tamra Bhasma
at different levels is not available.
Aim:
To evaluate the chemical changes in
Tamra Bhasma
at different steps by following Fourier transform infrared (FTIR) spectroscopy.
Materials and Methods:
In current study, raw
Tamra
, intermediate samples obtained during purification, incineration and
Amritikarana
were analyzed using FTIR.
Results:
It was observed that
Shodhana
procedure leads in the formation of bonds between surface particles of
Tamra
and
Shodhana
media. These formed bonds on the surface of
Shodhita Tamra
samples gave various sharp peaks representing presence of many functional groups.
Conclusion:
The FTIR spectra revealed that both
Bhasma
samples contained organic compounds probably in the form of a complex with common functional groups like alkyl, methyl, etc., which need further studies for exact characterization of the complexes.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4
3,279
346
CLINICAL RESEARCH
Clinical efficacy of
Vyaghriharitaki Avaleha
in the management of chronic bronchitis
Jaiprakash Ram, Madhav Singh Baghel
January-March 2015, 36(1):50-55
DOI
:10.4103/0974-8520.169009
PMID
:26730139
Introduction:
Vyaghriharitaki Avaleha
(VHA), a polyherbal classical Ayurvedic formulation has been used in
Kasa
(cough),
Swasa
(asthma),
Rajayakshma
(tuberculosis) etc., conditions.
Aim:
To evaluate the clinical efficacy of VHA in the management of chronic bronchitis.
Materials and Methods:
Patients of chronic bronchitis were given 10 g of VHA twice a day with lukewarm water before meals for 12 weeks. Improvement in clinical symptoms of chronic bronchitis as the primary outcome measures and St. George's Respiratory Questionnaire scores as secondary outcome measure was studied.
Results:
Out of 66 enrolled patients, 61 completed the treatment schedule. The results show that VHA provides statistically significant improvement with
P
< 0.001 in both primary and secondary outcome measures.
Conclusion:
VHA can be considered as a safe and effective formulation in the management of chronic bronchitis.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3
3,454
421
Role of
Agnikarma
in
Sandhigata Vata
(osteoarthritis of knee joint)
Nilesh G Jethava, Tukaram S Dudhamal, Sanjay Kumar Gupta
January-March 2015, 36(1):23-28
DOI
:10.4103/0974-8520.169017
PMID
:26730134
Introduction:
Sandhigata Vata
is one of
Vata Vyadhi
characterized by the symptoms such as
Sandhishoola
(joint pain) and
Sandhishopha
(swelling of joint)
.
Osteoarthritis (OA) is degenerative joint disorder, represents failure of the diarthrodial (movable, synovial-lined) joint. OA of knee joint comes under the inflammatory group which is almost identical to
Sandhigata Vata
described in Ayurveda with respect to etiology, pathology, and clinical features.
Agnikarma
(therapeutic heat burn) is one which gives instant relief from pain by balancing local
Vata
and
Kapha Dosha
without any untoward effects.
Aim:
To evaluate the efficacy of
Agnikarma
with
Rajata
and
Loha Dhatu Shalaka
in the management of
Janugata Sandhivata
(OA of knee joint).
Materials and Methods:
A total of 28 diagnosed patients of
Janugata Sandhivata
were registered and randomly divided into two groups. In Group-A,
Agnikarma
was done with
Rajata Shalaka
while in Group-B
Agnikarma
was performed by
Loha Shalaka
in four sittings. Assessment in relief of signs and symptoms was done by weekly interval, and Student's
t
-test was applied for statistical analysis.
Results:
Group-A provided 76.31% relief in pain while Group-B provided 83.77% relief. Relief from crepitus was observed in 57.13% of patients of Group-A, while 57.92% of patients of Group-B. There was statistically insignificant difference between both the groups.
Loha Shalaka
provided better result in pain relief than
Rajata Shalaka
.
Conclusion:
Agnikarma
is effective nonpharmacological, parasurgical procedure for pain management in
Sandhigata Vata
(OA of knee joint).
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3
12,340
833
PHARMACEUTICAL STANDARDIZATION
Accelerated stability studies of Sufoofe Sailan: A Unani formulation
Seema Rani, Khaleequr Rahman, Peerzada Mohammad Younis
January-March 2015, 36(1):83-90
DOI
:10.4103/0974-8520.169007
PMID
:26730145
Introduction:
Sufoofe Sailan
(SS) is a polyherbal powder preparation used in Unani medicine to treat gynecological diseases. It is observed that SS degrade early as it is in the form of powder; however, the stability study of SS was not carried out till date.
Aim:
To evaluate the accelerated stability of SS.
Materials and Methods:
Finished formulation of SS was packed in three airtight transparent polyethylene terephthalate containers. One pack was analyzed just after manufacturing and remaining two packs were kept in stability chamber at 40°C ± 2°C/75% ± 5% RH, of which one pack was analyzed after the completion of three and another after 6 months. Organoleptic, physico-chemical, microbiological parameters along with high-performance thin layer chromatography (HPTLC) fingerprinting were carried out.
Results:
Organoleptic characters showed no significant change in accelerated stability condition. All physico-chemical parameters showed changes <5%, HPTLC fingerprinting showed minimum changes and microbial studies were in confirmation to the World Health Organization guidelines.
Conclusion:
SS confirmed to the International Conference on Harmonization Guideline for accelerated testing of the pharmaceutical product on said parameters and as per the Grimm's statement the shelf life of SS may last 20 months.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3
5,237
400
Pharmacognostical and preliminary physico-chemical profiles of
Blepharispermum subsessile
DC. root
Amruta Jadhav, Rabinarayan Acharya, CR Harisha, Vinay J Shukla, Harimohan Chandola
January-March 2015, 36(1):73-76
DOI
:10.4103/0974-8520.169012
PMID
:26730143
Introduction:
Blepharispermum subsessile
DC. is a folklore medicinal herb, found in Odisha, Karnataka, Madhya Pradesh, and Maharashtra. It is locally known as
Rasnajhadi
in Odisha and its roots are being used as
Rasna
in treating rheumatic, gynecological, nervous disorders. In spite of its high medicinal as well as market values, the pharmacognostical characters of its root is not reported till date.
Aim:
To evaluate pharmacognostical and preliminary physico-chemical profiles of
B. subsessile
root.
Materials and Methods:
Roots of
B. subsessile
were collected from Odisha; its macroscopic, microscopic, powder characters and preliminary physico-chemical characters were studied following standard procedures.
Results:
Microscopically, outer multilayered lignified cork cells, cortex, border pitted xylem vessels, tracheids, isolated or groups of thick-walled xylem fibees were seen. Physico-chemical parameters showed that water soluble extractive value (31.3%) is more than alcohol soluble extractive value (23.2%) and 5.5 pH value, etc.
Conclusion:
The findings of the study will be useful in the identification and standardization of the
B. subsessile
root.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3
3,193
320
BOOK REVIEW
Science of
Marma
(in Ayurvedic diagnosis and treatment)
K Nishteswar
January-March 2015, 36(1):113-114
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
-
2,761
605
CLINICAL RESEARCH
Efficacy of
Yavakshara Taila Uttarabasti
in the management of fallopian tube blockage
Hetal P Baria, Shilpa B Donga, Laxmipriya Dei
January-March 2015, 36(1):29-33
DOI
:10.4103/0974-8520.169016
PMID
:26730135
Introduction:
Tubal blockage is one of the most common causative factors for female barrenness. It accounts for about 25-35% of female infertility. It is very difficult to manage, as the treatment choices for it are only tubal re-constructive surgery and
in vitro
fertilization (IVF). On the other hand, there is not established any reliable Ayurvedic treatment for the tubal blockage. It is the need of the time to establish an efficient and cost-effective therapy for this problem.
Aim:
To evaluate the efficacy of
Yavakshara Taila Uttarabasti
in fallopian tubal blockage.
Materials and Methods:
Patients of childbearing age with active marital life of 1 year or more, having complaint of failure to conceive with at least one fallopian tube blockage were selected. Total 19 patients were registered with 42.11% unilateral and 57.89% bilateral tubal blockage.
Yavakshara Taila
(5 ml) Intrauterine
Uttarabasti
was given for 6 days (with interval of 3 days in between), after completion of menstrual cycle for two consecutive cycles.
Results:
The tubal patency was found in 68.75% of patients and conception was achieved in 6.25% of patients.
Conclusion:
Yavakshara Taila Uttarabasti
an effective procedure for treating tubal blockage with no apparent evidence of complication.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
-
5,914
525
Effect of
Vatari Guggulu
in the management of
Gridhrasi
(sciatica)
Geeta V Sathavane, Darshana H Pandya, Madhav Singh Baghel
January-March 2015, 36(1):41-45
DOI
:10.4103/0974-8520.169019
PMID
:26730137
Introduction:
Low back pain is one of the common conditions of loco motor system disorder, affects people during their productive life. About 40% cases of low back pain are of radicular in origin and considered under the umbrella of sciatic syndrome. It is a pain dominant disease and reduces human activity considerably in terms of personal as well as social and professional life. The condition resembles disease
Gridhrasi
mentioned in Ayurveda under the umbrella of
Vatavyadhi
, and here piercing type of pain which restricts the movement of the affected leg, make his walking pattern-like bird vulture and put him in disgraceful condition.
Aim:
To assess the effect of
Vatari Guggulu
on the management of
Gridhrasi
.
Materials and Methods:
A total of 40 patients of
Gridhrasi
were registered and
Vatari Guggulu
3 tablet (500 mg each) twice a day was administered before meal with lukewarm water for 30 days.
Results and Conclusions:
About 32.35% of the patient improved moderately while mild improvement was observed in 47.09% of the patients. The drug has shown better effect on patients of
Vata Kaphaja
type of
Gridhrasi
in comparison of
Vataja
type of
Gridhrasi.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
-
9,258
654
EDITORIAL
Health promotion through Ayurveda
Mahesh Vyas
January-March 2015, 36(1):3-4
DOI
:10.4103/0974-8520.169005
PMID
:26730130
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
-
5,121
610
ORIGINAL ARTICLE - SURVEY STUDY
Assessment of prognostic aspects of cancer by
Taila Bindu Pariksha
Kalpana B Kachare, Anukul Chandra Kar
January-March 2015, 36(1):18-22
DOI
:10.4103/0974-8520.169003
PMID
:26730133
Introduction:
For the diagnosis of various aspects of disease and diseased person, several methods have been described in the Ayurvedic texts. These can be broadly classified into
Roga
and
Rogi Pariksha
. Several methods of
Roga-Rogi Pariksha
such as
Ashtasthana, Dashavidha, Dvadashavidha Pariksha
are described.
Mutra Pariksha
was the main laboratory investigative tools in the past and it is included under
Ashtasthana, Pariksha
. There is no direct description of methodology to ascertain the prognosis of cancer in the Ayurvedic classics.
Taila Bindu Pariksha
, which is a part of
Mutra Pariksha
helps in assessing the prognosis of a disease. Eastern Cooperative Oncology Group (ECOG) had developed the scale to ascertain prognosis of cancer in 1955. These ECOG performance scale gives doctors and research scholars a scale with which they can quickly assess the functional capacity of a patient and the progress of disease.
Aim:
To evaluate the prognosis of cancer by
Taila Bindu Pariksha
and compare the results with ECOG scale.
Materials and Methods:
A pilot study was undertaken on a single group of 20 cancer patients which are advised radio or chemotherapy for further management. The urine samples collected from the patients were subjected to
Taila Bindu Pariksha
. The ECOG scale was also assessed and compared with shape and direction of spread.
Result:
In majority of the patients, the correlation was found statistically highly significant.
Conclusion:
Taila Bindu Pariksha
may be used as an alternative method to ascertain the prognosis of the cancer patients.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
-
3,748
480
Feedback
Subscribe
Advertise
|
Sitemap
|
What's New
|
Feedback
|
Disclaimer
|
Privacy Notice
© AYU (An International Quarterly Journal of Research in Ayurveda) | Official publication of Institute For Post Graduate Teaching & Research in Ayurveda,Jamnagar | Published by Wolters Kluwer -
Medknow
Online since 1st Aug, 2010